<html lang="en">
<head>
<meta charset="utf-8"/>
<title offset="1783">Phenylalanine ammonia-lyase</title>
<script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_SVG.js" type="text/javascript">
</script>
</head>
<body>
<h1>Phenylalanine ammonia-lyase</h1>
<hr/>

<p><strong>Phenylalanine ammonia lyase</strong> () is an <a class="uri" href="enzyme" title="wikilink">enzyme</a> that <a href="catalysis" title="wikilink">catalyzes</a> a reaction converting L-<a class="uri" href="phenylalanine" title="wikilink">phenylalanine</a> to <a class="uri" href="ammonia" title="wikilink">ammonia</a> and <a href="cinnamic_acid" title="wikilink">trans-cinnamic acid</a>.<a class="footnoteRef" href="#fn1" id="fnref1"><sup>1</sup></a> Phenylalanine ammonia lyase (PAL) is the first and committed step in the <a href="Phenylpropanoids_metabolism" title="wikilink">phenyl propanoid pathway</a> and is therefore involved in the <a class="uri" href="biosynthesis" title="wikilink">biosynthesis</a> of the <a class="uri" href="polyphenol" title="wikilink">polyphenol</a> compounds such as <a href="flavonoid" title="wikilink">flavonoids</a>, <a href="phenylpropanoid" title="wikilink">phenylpropanoids</a>, and <a class="uri" href="lignin" title="wikilink">lignin</a> in <a class="uri" href="plants" title="wikilink">plants</a>.<a class="footnoteRef" href="#fn2" id="fnref2"><sup>2</sup></a><a class="footnoteRef" href="#fn3" id="fnref3"><sup>3</sup></a> Phenylalanine ammonia lyase is found widely in plants, as well as some <a class="uri" href="yeast" title="wikilink">yeast</a> and <a class="uri" href="fungi" title="wikilink">fungi</a>, with <a class="uri" href="isoenzymes" title="wikilink">isoenzymes</a> existing within many different species. It has a <a href="molecular_mass" title="wikilink">molecular mass</a> in the range of 270-330 kDa.<a class="footnoteRef" href="#fn4" id="fnref4"><sup>4</sup></a><a class="footnoteRef" href="#fn5" id="fnref5"><sup>5</sup></a> The activity of PAL is induced dramatically in response to various stimuli such as tissue wounding, <a href="pathogen" title="wikilink">pathogenic</a> attack, light, low temperatures, and <a href="plant_hormone" title="wikilink">hormones</a>.<a class="footnoteRef" href="#fn6" id="fnref6"><sup>6</sup></a><a class="footnoteRef" href="#fn7" id="fnref7"><sup>7</sup></a> PAL has recently been studied for possible therapeutic benefits in humans afflicted with <a class="uri" href="phenylketonuria" title="wikilink">phenylketonuria</a>.<a class="footnoteRef" href="#fn8" id="fnref8"><sup>8</sup></a> It has also been used in the generation of L-phenylalanine as precursor of the <a href="sugar_substitute" title="wikilink">sweetener</a> <a class="uri" href="aspartame" title="wikilink">aspartame</a>.<a class="footnoteRef" href="#fn9" id="fnref9"><sup>9</sup></a></p>

<p>The enzyme is a member of the ammonia <a class="uri" href="lyase" title="wikilink">lyase</a> family, which cleaves carbon-nitrogen bonds. Like other lyases, phenylalanine requires only one <a href="substrate_(biochemistry)" title="wikilink">substrate</a> for the forward reaction, but two for the reverse. It is thought to be mechanistically similar to the related enzyme <a href="histidine_ammonia-lyase" title="wikilink">histidine ammonia-lyase</a> (EC:4.3.1.3, HAL).<a class="footnoteRef" href="#fn10" id="fnref10"><sup>10</sup></a> The systematic name of this enzyme class is <strong>L-phenylalanine ammonia-lyase (trans-cinnamate-forming)</strong>. Previously, it was designated , but that class has been redesignated as EC 4.3.1.24 (phenylalanine ammonia-lyases),  (tyrosine ammonia-lyases), and  (phenylalanine/tyrosine ammonia-lyases). Other names in common use include <strong>tyrase</strong>, <strong>phenylalanine deaminase</strong>, <strong>tyrosine ammonia-lyase</strong>, <strong>L-tyrosine ammonia-lyase</strong>, <strong>phenylalanine ammonium-lyase</strong>, <strong>PAL</strong>, and <strong>L-phenylalanine ammonia-lyase</strong>.</p>
<h2 id="enzyme-mechanism">Enzyme Mechanism</h2>

<p>Phenylalanine ammonia lyase is specific for L-Phe, and to a lesser extent, <a href="tyrosine" title="wikilink">L-Tyrosine</a>.<a class="footnoteRef" href="#fn11" id="fnref11"><sup>11</sup></a> The reaction catalyzed by PAL is the spontaneous, non-<a href="oxidative_deamination" title="wikilink">oxidative deamination</a> of L-phenylalanine to yield trans-cinnamic acid and ammonia.<a class="footnoteRef" href="#fn12" id="fnref12"><sup>12</sup></a></p>
<dl>
<dd>L-phenylalanine 

<math display="inline" id="Phenylalanine_ammonia-lyase:0">
 <semantics>
  <mo>⇌</mo>
  <annotation-xml encoding="MathML-Content">
   <ci>normal-⇌</ci>
  </annotation-xml>
  <annotation encoding="application/x-tex">
   \rightleftharpoons
  </annotation>
 </semantics>
</math>

 <em>trans</em>-cinnamate + NH<sub>3</sub>
</dd>
</dl>

<p>The <a href="cofactor_(biochemistry)" title="wikilink">cofactor</a> <a class="uri" href="3,5-dihydro-5-methyldiene-4H-imidazol-4-one" title="wikilink">3,5-dihydro-5-methyldiene-4H-imidazol-4-one</a> (MIO) is involved in the reaction and sits atop the positive pole of three polar helices in the active site, which helps to increase its <a href="electrophile" title="wikilink">electrophilicity</a>.<a class="footnoteRef" href="#fn13" id="fnref13"><sup>13</sup></a> MIO is reported to attack the <a href="aromatic_hydrocarbon" title="wikilink">aromatic ring</a> of L-Phe in a <a href="Friedel-Crafts_reaction" title="wikilink">Friedel-Crafts-type reaction</a>, which activates the C-H bond and leads to cleavage of the bond.<a class="footnoteRef" href="#fn14" id="fnref14"><sup>14</sup></a> The <a class="uri" href="carbanion" title="wikilink">carbanion</a><a href="reaction_intermediate" title="wikilink">intermediate</a> formed by this mechanism is stabilized by partial positive regions in the active site. The mechanism of the reaction of PAL is thought to be similar to the mechanism of the related enzyme histidine ammonia lyase.<a class="footnoteRef" href="#fn15" id="fnref15"><sup>15</sup></a> PAL is inhibited by trans-cinnamic acid, and, in some species, may be inhibited trans-cinnamic acid derivatives.<a class="footnoteRef" href="#fn16" id="fnref16"><sup>16</sup></a><a class="footnoteRef" href="#fn17" id="fnref17"><sup>17</sup></a> D-Phe and D-Tyr are <a href="competitive_inhibition" title="wikilink">competitive inhibitors</a>.<a class="footnoteRef" href="#fn18" id="fnref18"><sup>18</sup></a></p>
<h2 id="enzyme-structure">Enzyme Structure</h2>

<p>Phenylalanine ammonia lyase is composed of four identical subunits composed mainly of <a class="uri" href="alpha-helices" title="wikilink">alpha-helices</a>, with pairs of <a class="uri" href="monomers" title="wikilink">monomers</a> forming a single <a href="active_site" title="wikilink">active site</a>.<a class="footnoteRef" href="#fn19" id="fnref19"><sup>19</sup></a> Catalysis in PAL may be governed by the <a href="Bond_dipole_moment" title="wikilink">dipole moments</a> of seven different alpha helices associated with the active site.<a class="footnoteRef" href="#fn20" id="fnref20"><sup>20</sup></a> The active site contains the electrophilic group MIO non-covalently bonded to three helices. Leu266, Asn270, Val269, Leu215, Lys486, and Ile472 are located on the active site helices, while Phe413, Glu496, and Gln500 contribute to the stabilization of the MIO cofactor. The orientation of dipole moments generated by helices within the active site generates an electropositive region for ideal reactivity with MIO. The partially positive regions in the active site may also help stabilize the charge of a carbanion intermediate. PAL is structurally similar to the mechanistically related histidine ammonia lyase, although PAL has approximately 215 additional residues.<a class="footnoteRef" href="#fn21" id="fnref21"><sup>21</sup></a></p>
<h2 id="biological-function">Biological Function</h2>

<p>Phenylalanine ammonia lyase can perform different functions in different species. It is found mainly in some plants, fungi, and yeast. In fungal and yeast cells, PAL plays an important <a class="uri" href="catabolic" title="wikilink">catabolic</a> role, generating <a class="uri" href="carbon" title="wikilink">carbon</a> and <a class="uri" href="nitrogen" title="wikilink">nitrogen</a>.<a class="footnoteRef" href="#fn22" id="fnref22"><sup>22</sup></a> In plants it is a key biosynthetic enzyme that catalyzes the first step in the synthesis of a variety of polyphenyl compounds <a class="footnoteRef" href="#fn23" id="fnref23"><sup>23</sup></a><a class="footnoteRef" href="#fn24" id="fnref24"><sup>24</sup></a> and is mainly involved in defense mechanisms. PAL is involved in 5 <a href="metabolism" title="wikilink">metabolic pathways</a>: <a href="tyrosine_metabolism" title="wikilink">tyrosine metabolism</a>, <a href="phenylalanine_metabolism" title="wikilink">phenylalanine metabolism</a>, <a href="nitrogen_metabolism" title="wikilink">nitrogen metabolism</a>, <a href="phenylpropanoid_biosynthesis" title="wikilink">phenylpropanoid biosynthesis</a>, and <a href="alkaloid_biosynthesis_ii" title="wikilink">alkaloid biosynthesis ii</a>.</p>
<h2 id="disease-relevance">Disease Relevance</h2>

<p>Researchers are exploring enzyme substitution therapy using PAL to treat phenylketonuria (PKU), an autosomal recessive genetic disorder in humans in which mutations in the <a href="phenylalanine_hydroxylase" title="wikilink">phenylalanine hydroxylase</a> (PAH, EC 1.14.16.1) gene inactivate the enzyme.<a class="footnoteRef" href="#fn25" id="fnref25"><sup>25</sup></a> This leads to an inability of the patient to metabolize phenylalanine, causing elevated levels of Phe in the bloodstream (<a class="uri" href="hyperphenylalaninemia" title="wikilink">hyperphenylalaninemia</a>) and mental retardation if therapy is not begun at birth.<a class="footnoteRef" href="#fn26" id="fnref26"><sup>26</sup></a> Treatment in mouse models using <a href="Recombinant_DNA" title="wikilink">recombinant</a> PAL has been shown to lower <a href="blood_plasma" title="wikilink">plasma</a> Phe level, converting L-Phe to harmless metabolites that can be excreted. In order to reduce the <a class="uri" href="immunogenicity" title="wikilink">immunogenicity</a> of PAL, the enzyme is modified by <a class="uri" href="PEGylation" title="wikilink">PEGylation</a>. This process disguises the introduced PAL from the host’s <a href="immune_system" title="wikilink">immune system</a> and can lead to a longer and more effective reduction in blood Phe levels than non-modified PAL.<a class="footnoteRef" href="#fn27" id="fnref27"><sup>27</sup></a></p>

<p>Current treatment for PKU requires patients to adhere to a specific diet their whole life, which can be difficult to maintain and may contribute to birth defects if pregnant patients are not careful enough.<a class="footnoteRef" href="#fn28" id="fnref28"><sup>28</sup></a> Therefore, continued research into the development of enzyme therapy using PAL is of interest for the medical community.</p>

<p>PAL may also be used in the treatment of certain forms of mouse <a href="neoplasm" title="wikilink">neoplastic</a> <a class="uri" href="tumors" title="wikilink">tumors</a>.<a class="footnoteRef" href="#fn29" id="fnref29"><sup>29</sup></a></p>
<h2 id="industrial-relevance">Industrial Relevance</h2>
<h3 id="artificial-sweeteners">Artificial Sweeteners</h3>

<p>The reverse reaction catalyzed by PAL has been used to convert trans-cinnamic acid to L-phenylalanine, which is a precursor of the sweetener aspartame. This process was developed by Genex Corporation in the USA using yeast <a class="uri" href="Rhodotorula" title="wikilink">Rhodotorula</a> cells (U.S Patents No. 4,574,117; 4,584,269; 4,584,273; 4,598,047; 4,636,466; 4,681,850; 4,757,015).<a class="footnoteRef" href="#fn30" id="fnref30"><sup>30</sup></a></p>
<h3 id="unnatural-amino-acid-synthesis">Unnatural Amino Acid Synthesis</h3>

<p>Analogous to how aspartame is synthesized, PAL is also used to synthesize <a href="Non-proteinogenic_amino_acids" title="wikilink">unnatural amino acids</a> from various <a class="uri" href="substituted" title="wikilink">substituted</a> <a href="cinnamic_acids" title="wikilink">cinnamic acids</a> for research purposes.<a class="footnoteRef" href="#fn31" id="fnref31"><sup>31</sup></a> <a href="Steric_hindrance" title="wikilink">Steric hindrance</a> from <a href="arene_substitution_pattern" title="wikilink">arene substitution</a> limits PAL's utility for this purpose however.<a class="footnoteRef" href="#fn32" id="fnref32"><sup>32</sup></a> For instance, when <a href="Rhodotorula" title="wikilink"><em>Rhodotorula glutinis</em></a> was used to affect this <a class="uri" href="biotransformation" title="wikilink">biotransformation</a> the enzyme was discovered to be intolerant of all para substituents other than <a href="Organofluorine_compound" title="wikilink">fluoride</a> <a href="Substrate_analog" title="wikilink">analogs</a>, presumably due to the element's small <a href="atomic_radius" title="wikilink">atomic radius</a>. Meta and ortho positions were found to be more tolerant, but still limited by, larger substituents. For instance the enzyme's <a href="active_site" title="wikilink">active site</a> permitted <a class="uri" href="methoxy" title="wikilink">methoxy</a> substitution but forbid <a class="uri" href="ethoxy" title="wikilink">ethoxy</a>. Other organisms with different versions of the enzyme may be less limited in this way.<a class="footnoteRef" href="#fn33" id="fnref33"><sup>33</sup></a><a class="footnoteRef" href="#fn34" id="fnref34"><sup>34</sup></a></p>
<h2 id="structural-studies">Structural studies</h2>

<p>As of late 2007, 5 <a href="tertiary_structure" title="wikilink">structures</a> have been solved for this class of enzymes, with <a href="Protein_Data_Bank" title="wikilink">PDB</a> accession codes , , , , and .</p>
<h2 id="references">References</h2>
<ul>
<li></li>
<li></li>
</ul>

<p>"</p>

<p><a href="Category:EC_4.3.1" title="wikilink">Category:EC 4.3.1</a> <a href="Category:Enzymes_of_known_structure" title="wikilink">Category:Enzymes of known structure</a> <a href="Category:Natural_phenols_metabolism" title="wikilink">Category:Natural phenols metabolism</a></p>
<section class="footnotes">
<hr/>
<ol>
<li id="fn1"><a href="#fnref1">↩</a></li>
<li id="fn2"></li>
<li id="fn3"></li>
<li id="fn4"></li>
<li id="fn5"><a href="#fnref5">↩</a></li>
<li id="fn6"></li>
<li id="fn7"><a href="#fnref7">↩</a></li>
<li id="fn8"></li>
<li id="fn9"><a href="#fnref9">↩</a></li>
<li id="fn10"><a href="#fnref10">↩</a></li>
<li id="fn11"><a href="#fnref11">↩</a></li>
<li id="fn12"><a href="#fnref12">↩</a></li>
<li id="fn13"><a href="#fnref13">↩</a></li>
<li id="fn14"><a href="#fnref14">↩</a></li>
<li id="fn15"></li>
<li id="fn16"></li>
<li id="fn17"><a href="#fnref17">↩</a></li>
<li id="fn18"></li>
<li id="fn19"><a href="#fnref19">↩</a></li>
<li id="fn20"><a href="#fnref20">↩</a></li>
<li id="fn21"></li>
<li id="fn22"></li>
<li id="fn23"></li>
<li id="fn24"></li>
<li id="fn25"><a href="#fnref25">↩</a></li>
<li id="fn26"></li>
<li id="fn27"><a href="#fnref27">↩</a></li>
<li id="fn28"><a href="#fnref28">↩</a></li>
<li id="fn29"></li>
<li id="fn30"></li>
<li id="fn31"><a href="#fnref31">↩</a></li>
<li id="fn32"><a href="#fnref32">↩</a></li>
<li id="fn33"><a href="#fnref33">↩</a></li>
<li id="fn34"><a href="#fnref34">↩</a></li>
</ol>
</section>
</body>
</html>
